Robyn Kendall, MSc, BSc

Director of Health Economics

Robyn Kendall is Evidinno’s Director of Health Economics and she has worked as a consultant in the research industry for over 17 years, specializing in Health Economics for the last 15 years. Consultancy work has provided her exposure to a number of economic disciplines including economic evaluation, policy analysis, and infrastructure forecasting. Her experience in Health Economics covers a range of methodologies including cost-effectiveness/cost-utility modelling (including Markov modelling and Monte Carlo simulation), budget impact modelling, cost-benefit analysis, and cost-minimization analysis. Robyn has worked on projects in a variety of therapeutic areas including oncology, respiratory illnesses, lupus, diabetes, paediatric vaccines, and infectious diseases. Robyn earned her MSc in Health Economics from the University of York in the UK, and her BSc in Cell Biology and Genetics from the University of British Columbia.